Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2011
02/08/2011USRE42126 system for delivering oral care substance to oral cavity comprising a removable backing strip having sufficient flexibility to be conformable to oral surface and oral care composition that forms film when applied to backing strip comprising organosiloxane resin, rheology modifier, and oral care substance
02/08/2011US7884227 Felbamate with improved bulk density
02/08/2011US7884222 Process for the production of tibolone
02/08/2011US7884221 Method of separating ergosterol
02/08/2011US7884217 Antidiabetic agents
02/08/2011US7884216 Fluorine-containing pyrazolecarbonitrile derivative and method for producing the same, and fluorine-containing pyrazolecarboxylic acid derivative obtained by using the fluorine-containing pyrazolecarbonitrile derivative and method for producing the same
02/08/2011US7884213 Process for the preparation of anastrozole
02/08/2011US7884211 2-Methylamino-N-{2-(6-{1-methyl-2-(2-methylamino-propionylamino)-3-oxo-3-[2-(5-phenoxy-tetrazol-1-ylmethyl)-pyrrolidine-1-yl]-propoxy}-hexa-2,4-diynyloxy)-1-[2-(5-phenoxy-tetrazol-1-ylmethyl)-pyrrolidine-1-carbonyl]-propyl}-propionamide; mimetics of second mitochondria-derived activator of caspases
02/08/2011US7884207 such as 4-[(4-Amino-2-butyl-1H-imidazo[4,5-c]quinolin-1-yl)methyl]tetrahydro-2H-pyran-4-ol, used as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases
02/08/2011US7884206 Method for producing 3-amidinophenylalanine derivatives
02/08/2011US7884205 Salts of aripiprazole
02/08/2011US7884204 Phenylalanine derivatives
02/08/2011US7884199 HCV NS3-NS4 protease resistance mutants
02/08/2011US7884197 oligonucleotide-based compounds that individually provide distinct immune response profiles through their interactions as agonists with Toll-like receptors (TLR9)
02/08/2011US7884180 binds formyl peptide receptor-like 1 (FPRL1); useful for treating disorders associated with G-protein coupled receptor activation
02/08/2011US7884179 monoclonal antibodies or antigen binding fragments that specifically to six transmembrane epithelial antigens of the prostate (STEAP-1), used for medical diagnosis, prognosis, prophylaxis and/or therapy for cancers
02/08/2011US7884136 bupropion hydrobromide, used for the treatment of depression, nicotine addiction and obesity
02/08/2011US7884135 via fast disintegrating tablets, mucoadhesive films; pharmacokinetics
02/08/2011US7884134 Synthesis scheme for lacosamide
02/08/2011US7884133 cannabidiol derivatives such as 3-(2,6-dihydroxy-4-pentylphenyl)-4-prop-1-en-2-ylcyclohexene-1-carboxylic acid, used as as analgesics, antiinflammatory and antidiarrheal agents
02/08/2011US7884132 comprises trisodium citrate; dialysates; renal diseases
02/08/2011US7884131 isolated, tri-hydroxy derivatives, docosanoids; for nutritional compositions and cosmetics
02/08/2011US7884130 Gamma-undecenolactone, method for the preparation and use thereof for cosmetics and in the form of food additives
02/08/2011US7884128 reacting 11-{[tert-butyl(dimethyl)silyl]oxy}-7-[(E)-2-formyl-1-methyleth-1-en-1-yl]-6,13a-dimethyl-2-phenyl-3a,6,7,10,11,12,13,13a-octahydro-9H-[1,3]dioxolo[4,5-f]oxacyclododecin-9-one with 2-methyl-3-[(1-phenyl-1H-tetrazol-5-yl)sulfonyl]propyl}oxiran-2-yl)pentane-3-ol, to form pladienolide analogues
02/08/2011US7884127 chromenone derivatives of nitrogen-, oxygen- or sulfur-containing saturated heterocycles; preparation by cyclizing benzoyl intermediates; antiproliferative agents; 2-(2-Chloro-phenyl)-8-(2-hydroxymethyl-1-methyl-pyrrolidin-3-yl)-5,7-dimethoxy-chromen-4-one; acidification
02/08/2011US7884126 Indazole-heteroaryl derivatives
02/08/2011US7884125 7-benzyl-7-azabicyclo[2.2.1]hept-1-ylmethyl)-pyridin-2-yl-amine, used for the treatment of diseases mediated by Nicotinic Acetylcholine Receptors, such as pain, Alzheimer's disease, Parkinson's disease, schizophrenia, epilepsy and drug addiction
02/08/2011US7884124 Fluoro-substituted inhibitors of D-amino acid oxidase
02/08/2011US7884123 3-(1H-indol-2-yl)-1H-thieno[2,3-c]pyrazole-5-(N-phenoxycarboxamide); anticancer agents; protein kinase inhibitors
02/08/2011US7884122 Extended release formulation and method of treating adrenergic dysregulation
02/08/2011US7884121 Process for the preparation of phenylcarbamates
02/08/2011US7884120 microbiocides such as 2-(2-methyl-1H-indol-3-yl)-3a,11b-dihydro-1H-phenanthro[9,10-d]imidazole; bactericides; fungicides
02/08/2011US7884119 Triazole derivatives useful as Axl inhibitors
02/08/2011US7884118 such as 1-Cyclopentyl-5-iodotetrazole, suitable as microbicides for protecting plants and materials
02/08/2011US7884117 Protein kinase inhibitors such as (S)-2-(methylamino)-1-phenylethyl 3-(4-fluorobenzamido)-6,6-dimethylpyrrolo[3,4-c]pyrazole-5(1H,4H,6H)-carboxylate, used for the treatment of abnormal cell growth in mammals; antiproliferative agents
02/08/2011US7884116 N-(pyridin-3-ylmethyl)-(2E,4E)-5-[(1S,2S,4aR,6R,7S,8S,8aS)-7-hydroxy-2,6,8-trimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-2-methylpenta-2,4-dienamide, having cell adhesion molecule gene experssion inhibitory activty, used for treating inflammatory diseases, arthritis and as immunosuppressants
02/08/2011US7884115 Composition comprising N-butyl-1-deoxy-nojirimycin, D-glucaro-delta-lactam, and N-ethyl-1-dexynojirimycin in a pharmaceutically acceptable carrier; treatment of chronic pain and neurodegeneration, neuropathic pain, visceral pain, fibromyalgia pain, inflammatory pain, headache pain, muscle pain
02/08/2011US7884114 N-(4-{4-[(6-butyl-8-quinolinyl)oxy]-1-piperidinyl}butyl)ethanesulfonamide for treatment of allergic rhinitis
02/08/2011US7884113 Eating and metabolism disorders; obesity; metabolism disorders; central nervous system disorders; analgesics; antiinflammatory agents; cognition activators
02/08/2011US7884112 Pyrrolopyridine-2-carboxylic acid hydrazides
02/08/2011US7884111 2,4-pyrimidinediamine compounds and uses as anti-proliferative agents
02/08/2011US7884110 4-Chloro-N-[5-methyl-2-(7H-pyrrolo[2,3-d]pyrimidine-4-carbonyl)-pyridin-3-yl]-3-trifluoromethyl-benzenesulfonamide sodium salt; for chemokine-mediated conditions or diseases including certain inflammatory and immunoregulatory disorders; restenosis, multiple sclerosis, arthritis
02/08/2011US7884109 immunosuppressants such as 2-(6-Fluoro-1H-benzo[d]imidazol-1-yl)-9-((1R,4R)-4-hydroxy-1,2,3,4-tetrahydronaphthalen-1-yl)-7H-purin-8(9H)-one, used for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection
02/08/2011US7884108 Certain substituted pyrazinones
02/08/2011US7884107 Substituted piperidines that increase P53 activity and the uses thereof
02/08/2011US7884106 Method of stabilizing lipid-rich plaque and method of preventing rupture thereof
02/08/2011US7884105 Squaric acid derivatives as inhibitors of histone deacetylase
02/08/2011US7884104 Such as (3R,4R)-1-Pyrimidin-4-yl-4-(2,4,5-trifluorophenyl)piperidin-3-amine bis-trifluoroacetic acid salt
02/08/2011US7884103 such as N-(4-Chloro-phenyl)-2-methyl-2-phenylmethanesulfonylamino-3-(4-[1,2,4]triazol-1-yl-phenoxy)-propionamide, used for controlling or preventing the infestation of plants by phytopathogenic microorganisms, especially fungi
02/08/2011US7884102 Substituted piperidine compounds and methods of their use
02/08/2011US7884101 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
02/08/2011US7884100 selective antagonists of A2B adenosine receptors for treatment of asthma, diabetic retinopathy
02/08/2011US7884099 such as (R)-5'-[3-{1-(4-{1-[1-(3-Carboxy-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-8-yl)-pyrrolidin-3-yl-cyclopropyl]-methylamino}-piperidin-1-yl]-3'-hydroxy-benzoxazinorifamycin, useful as bactericides for the treatment of bacterial infections
02/08/2011US7884098 Anthranilamide inhibitors of aurora kinase
02/08/2011US7884097 Methods and compositions comprising diamines as new anti-tubercular therapeutics
02/08/2011US7884096 Psychological disorders; central nervous system disorders; anxiolytic agents; using pipamperone
02/08/2011US7884095 Method of treating post-surgical acute pain
02/08/2011US7884094 Compounds for the treatment of proliferative disorders
02/08/2011US7884093 treating short cervix, increasing neonatal health
02/08/2011US7884092 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
02/08/2011US7884091 Methods for treating delirium using glucocorticoid receptor-specific antagonists
02/08/2011US7884090 Compositions and methods for the treatment of arthritis
02/08/2011US7884088 biocompatible oligomers such as oligochitin, oligochitosan in solvent such as dimethylsulfoxide, admixing pi complex; for drug detoxification
02/08/2011US7884087 Amides of hyaluronic acid the derivatives thereof and a process for their preparation
02/08/2011US7884086 identifying siRNA and double-stranded RNA compounds, having bioactivity in vivo; nucleosides
02/08/2011US7884083 Immunomodulatory compositions, methods of making, and methods of use thereof
02/08/2011US7884082 Combined therapeutical treatment of hyperproliferative diseases
02/08/2011US7884081 Methods of modulating tubulin deacetylast activity
02/08/2011US7884080 Administering an azetidinone compound for treating a disorder of lipid metabolism, pain, diabetes, a vascular condition, demyelination or nonalcoholic fatty liver disease; T-type calcium channel blocking agent, an antagonist of TRPV1, an agonist of TRPV1, of GPR119, antagonist of NPCL1
02/08/2011US7884079 4-aminopyridine and a pharmaceutical composition for treatment of neuronal disorders
02/08/2011US7884077 administering kappa agonist partial agonist such as pentazocine and naloxone to stabilize mood
02/08/2011US7884072 produce more stem cells in vivo or in vitro by culture, for transplantation into patient; increase neurogenesis or new olfactory neuron numbers; stroke, neurodegenerative disease of Alzheimer's disease, multiple sclerosis, Huntington's disease, amyotrophic lateral sclerosis, and Parkinson's disease
02/08/2011US7883897 Method for producing purified hematinic iron-saccharadic complex and product produced
02/08/2011US7883881 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease
02/08/2011US7883874 Bifidobacterium hifidum capable of producing a galactosidase enzyme activity that converts lactose to a mixture of galactooligosaccharides; for improving gut health by promoting the growth of bifidobacteria, and repressing the growth of the pathogenic microflora; treating inflammatory bowel disease
02/08/2011US7883868 Nucleotide sequences coding beta -10 glycoprotein hormone use in diagnosis and prevention of thyroid gland disorders
02/08/2011US7883729 Natural vegetable oil concentrated in unsaponifiable matters as food ingredient
02/08/2011US7883725 kits comprising liquid or dry acid concentrate unit stored in first vessel, and liquid or dry citrate-containing bicarbonate concentrate unit stored in second vessel; contents of first and second vessels are emptied into dialysate preparation tank and mixed with water to form batch of dialysate
02/08/2011US7883723 Water soluble chitosan nanoparticle for delivering an anticancer agent and preparing method thereof
02/08/2011US7883719 Pasting agent
02/08/2011US7883718 Methods and devices for the sustained release of multiple drugs
02/08/2011US7883715 Pesticide compositions containing dicarboxylic acids
02/08/2011US7883714 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
02/08/2011US7883713 Suspension, ointment, solution, spray, lotion, gel, cream, powder, powder spray, paste, emulsion, foam or stick; for treatment of herpes infections in humans
02/08/2011US7883708 Substance derived from basidiomycetes culture, method for producing it and its use
02/08/2011US7883707 Induction of antigen specific immunnologic tolerance
02/08/2011US7883694 Method for preventing the formation of adhesions following surgery or injury
02/08/2011US7883693 Compositions and systems for forming crosslinked biomaterials and methods of preparation of use
02/08/2011CA2622694C Substituted cycloalkene derivative
02/08/2011CA2615991C Substituted propanamide derivative and pharmaceutical composition comprising the same
02/08/2011CA2610888C Inhibitors of akt activity
02/08/2011CA2605899C Triazole derivatives as vasopressin antagonists
02/08/2011CA2603784C 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
02/08/2011CA2602781C 1h-pyrazole 4-carboxylamides, their preparation and their use as 11beta-hydroxysteroid dehydrogenase
02/08/2011CA2586179C Sulfonyl benzimidazole derivatives
02/08/2011CA2562951C Indene derivatives and process for the preparation thereof
02/08/2011CA2559808C Spermicidal and virucidal properties of various forms of sophorolipids
02/08/2011CA2553785C Compounds and compositions as protein kinase inhibitors
02/08/2011CA2540984C A solid dosage form comprising a fibrate
02/08/2011CA2484450C Ligands that are inhibitors of the rar receptors